Advanced Medical Solutions Grp PLC
21 February 2001
ADVANCED MEDICAL SOLUTIONS AWARDED TISSUE ENGINEERING GRANTS FROM GLASGOW AND
ASTON UNIVERSITIES
Advanced Medical Solutions Group plc has been awarded grants totalling
£130,000, in support of the company's research on tissue engineering.
The grants to investigate cell-fibre interactions have been awarded for
projects in conjunction with the Universities of Aston and Glasgow.
As part of a consortium under the leadership of Professor Adam Curtis of the
Department of Cellular Engineering at the University of Glasgow, Advanced
Medical Solutions will develop cell-fibre scaffolds for a project entitled
'Nanobiotechnology and Medicine'. The research is financed under the European
Framework V Scheme.
Further work on the development of cell-fibre scaffolds to support endothelial
cell growth will be performed as part of a project entitled 'Improving the
design of small bore vascular grafts'. This work is to be performed in
association with Drs Helen Griffiths and Allan Coombes of the Pharmaceutical
Sciences Research Institute, Aston University, and is supported under the
Dti/Teaching Company scheme.
Don Evans, Chief Executive of Advanced Medical Solutions said:
'We are delighted to receive these awards which provide academic validation of
our work on cell-fibre interactions. They not only provide financial support
for the research but also strengthen our relationships with two of the UK's
most prestigious universities in this field.
'The grants will help us to progress this key area of our research activities
and will provide the technology for us to enhance our current advanced
woundcare product range. They will also provide a basis from which to deliver
core technology in other added value medical device areas.'
For press enquiries please contact:
Advanced Medical Solutions Group plc Tel: 01606 863500
Don Evans, Chief Executive
Mary Tavener, Finance Director
www.admedsol.com
Gavin Anderson & Company Tel: 0207 457 2345
Charlotte Stone
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.